Christine L. Chung
2019
In 2019, Christine L. Chung earned a total compensation of $4.6M as Senior Vice President, China Operations at FibroGen.
Compensation breakdown
| Non-Equity Incentive Plan | $243,320 |
|---|---|
| Option Awards | $1,366,680 |
| Salary | $440,000 |
| Stock Awards | $2,522,520 |
| Other | $17,766 |
| Total | $4,590,286 |
Chung received $2.5M in stock awards, accounting for 55% of the total pay in 2019.
Chung also received $243.3K in non-equity incentive plan, $1.4M in option awards, $440K in salary and $17.8K in other compensation.
Rankings
In 2019, Christine L. Chung's compensation ranked 2,476th out of 13,971 executives tracked by ExecPay. In other words, Chung earned more than 82.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,476 out of 13,971 | 82nd |
Division Manufacturing | 891 out of 5,701 | 84th |
Major group Chemicals And Allied Products | 288 out of 2,200 | 87th |
Industry group Drugs | 232 out of 1,886 | 88th |
Industry Pharmaceutical Preparations | 171 out of 1,398 | 88th |
Source: SEC filing on April 23, 2020.
Chung's colleagues
We found five more compensation records of executives who worked with Christine L. Chung at FibroGen in 2019.
2019
Thomas Neff
FibroGen
Chief Executive Officer
2019
K Yu
FibroGen
Chief Medical Officer
2019
James Schoeneck
FibroGen
Chief Executive Officer
2019
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
2019
Pat Cotroneo
FibroGen